Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Centogene Announces Initial Data From ROPAD Study Showing 90% Of Genetically Confirmed Parkinson's Patients Have LRRK2 Or GBA1 Variants; Findings Indicate 15% Of PD Cases Linked To Genetic Variants; Data Published In Brain Journal Highlights Importance Of Genetic Testing In Gene-Targeted Trials

Author: Benzinga Newsdesk | August 01, 2024 04:50pm

Posted In: CNTG